Cargando…
H1.0 induces paclitaxel‐resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor
More than 90% of ovarian cancer deaths are due to relapse following development of chemoresistance. Our main objective is to better understand the molecular mechanism underlying paclitaxel resistance (taxol resistance, Txr) in ovarian cancer. Here, we observed that the linker histone H1.0 is upregul...
Autores principales: | Kohli, Abhidha, Huang, Shang‐Lang, Chang, Ting‐Chang, Chao, Chuck C.‐K., Sun, Nian‐Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357662/ https://www.ncbi.nlm.nih.gov/pubmed/35639349 http://dx.doi.org/10.1111/cas.15448 |
Ejemplares similares
-
Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor
por: Sun, Nian-Kang, et al.
Publicado: (2015) -
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response
por: Sun, Nian-Kang, et al.
Publicado: (2014) -
The Sas3p and Gcn5p histone acetyltransferases are recruited to similar genes
por: Rosaleny, Lorena E, et al.
Publicado: (2007) -
PPA-GCN: A Efficient GCN Framework for Prokaryotic Pathways Assignment
por: Lu, Yuntao, et al.
Publicado: (2022) -
GCN-5/PGC-1α signaling is activated and associated with metabolism in cyclin E1-driven ovarian cancer
por: Guo, Ting, et al.
Publicado: (2019)